Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 4, 2004 - Issue 5
Submit an article Journal homepage
25
Views
10
CrossRef citations to date
0
Altmetric
Review

Cost-effectiveness lessons from disease-modifying drugs in the treatment of multiple sclerosis

Jeffrey S Hoch University of Western Ontario, Department of Epidemiology and Biostatistics, London, Ontario, N6A 5C1, Canada. [email protected]
Pages 537-547 | Published online: 09 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Emanuele D’Amico, Clara G Chisari, Lara Gitto, Aurora Zanghì, Simona Toscano & Francesco Patti. (2019) Pharmacoeconomics of synthetic therapies for multiple sclerosis. Expert Opinion on Pharmacotherapy 20:11, pages 1331-1340.
Read now

Articles from other publishers (9)

Steven Simoens. (2022) Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies. Frontiers in Neurology 13.
Crossref
Annie Hawton & Colin Green. (2016) Health Utilities for Multiple Sclerosis. Value in Health 19:4, pages 460-468.
Crossref
Annie Hawton, James Shearer, Elizabeth Goodwin & Colin Green. (2013) Squinting Through Layers of Fog: Assessing the Cost Effectiveness of Treatments for Multiple Sclerosis. Applied Health Economics and Health Policy 11:4, pages 331-341.
Crossref
Jeffrey S. Hoch. 2010. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer 543 569 .
Michael Busch, Mark Walderhaug, Brian Custer, Jean-Pierre Allain, Ravi Reddy & Brian McDonough. (2009) Risk assessment and cost-effectiveness/utility analysis. Biologicals 37:2, pages 78-87.
Crossref
Brian Custer & Jeffrey S. Hoch. (2009) Cost-Effectiveness Analysis: What It Really Means for Transfusion Medicine Decision Making. Transfusion Medicine Reviews 23:1, pages 1-12.
Crossref
Jeffrey S Hoch & Carolyn S Dewa. (2007) Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions. PharmacoEconomics 25:10, pages 807-816.
Crossref
Jeffrey S. Hoch & Mark W. Smith. (2006) A guide to economic evaluation: Methods for cost-effectiveness analysis of person-level data. Journal of Traumatic Stress 19:6, pages 787-797.
Crossref
Maurice McGregor & J Jaime Caro. (2006) QALYs. PharmacoEconomics 24:10, pages 947-952.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.